ArticleJournal of oral and maxillofacial pathology : JOMFP
Serum C-reactive protein/albumin ratio as a prognostic marker in oral squamous cell carcinoma.
Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Systemic inflammation in response to oral squamous cell carcinoma (OSCC) has been known to be a detrimental factor for the prognosis of the patients. Inflammation-based predictive biomarkers, like levels of serum C-reactive protein (CRP) and albumin, have been associated with rise and decline, respectively, with the advancement of malignancy. A ratio of their serum levels is being recently advocated to be a better prognostic predictor. We evaluated the association of the ratio of serum CRP and albumin with the clinical stage and histological grade of OSCC. Methods: Thirty-five histopathologically confirmed patients of OSCC were included in the study, and the serum levels of CRP, albumin, and ratio of the serum CRP and albumin levels were measured in patients with different clinical stages and histological grades of the OSCC. Results: Serum CRP levels showed a progressive statistically significant increase with the advancement of the clinical stage from stage I to stage IV and histological grade of OSCC. The serum levels of albumin exhibited a progressive decline, though statistically insignificant, with the advancement of clinical stage and histological grade of OSCC. The mean value of the ratio of serum CRP and albumin progressively increased with the clinical stage and histological grade of OSCC. Pearson's correlation analysis revealed a significant correlation of the ratio of serum CRP and albumin with the clinical stage of OSCC, although not with the histological grade of OSCC. Conclusion: The ratio of serum CRP and albumin can be employed as a serological marker for the prognosis of OSCC and may aid in the postoperative monitoring of the patients with OSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.